Literature DB >> 23269735

Longitudinal analyses of gut mucosal microbiotas in ulcerative colitis in relation to patient age and disease severity and duration.

Alemu Fite1, Sandra Macfarlane, Elizabeth Furrie, Bahram Bahrami, John H Cummings, Douglas T Steinke, George T Macfarlane.   

Abstract

Bacteria belonging to the normal colonic microbiota are associated with the etiology of ulcerative colitis (UC). Although several mucosal species have been implicated in the disease process, the organisms and mechanisms involved are unknown. The aim of this investigation was to characterize mucosal biofilm communities over time and to determine the relationship of these bacteria to patient age and disease severity and duration. Multiple rectal biopsy specimens were taken from 33 patients with active UC over a period of 1 year. Real-time PCR was used to quantify mucosal bacteria in UC patients compared to 18 noninflammatory bowel disease controls, and the relationship between indicators of disease severity and bacterial colonization was evaluated by linear regression analysis. Significant differences were detected in bacterial populations on the UC mucosa and in the control group, which varied over the study period. High clinical activity indices (CAI) and sigmoidoscopy scores (SS) were associated with enterobacteria, desulfovibrios, type E Clostridium perfringens, and Enterococcus faecalis, whereas the reverse was true for Clostridium butyricum, Ruminococcus albus, and Eubacterium rectale. Lactobacillus and bifidobacterium numbers were linked with low CAI. Only E. rectale and Clostridium clostridioforme had a high age dependence. These findings demonstrated that longitudinal variations in mucosal bacterial populations occur in UC and that bacterial community structure is related to disease severity.

Entities:  

Mesh:

Year:  2012        PMID: 23269735      PMCID: PMC3592070          DOI: 10.1128/JCM.02574-12

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  51 in total

Review 1.  Mucosal biofilm communities in the human intestinal tract.

Authors:  Sandra Macfarlane; Bahram Bahrami; George T Macfarlane
Journal:  Adv Appl Microbiol       Date:  2011       Impact factor: 5.086

2.  Molecular characterization of rectal mucosa-associated bacterial flora in inflammatory bowel disease.

Authors:  Maria Mylonaki; Neil B Rayment; David S Rampton; Barry N Hudspith; Jonathan Brostoff
Journal:  Inflamm Bowel Dis       Date:  2005-05       Impact factor: 5.325

3.  Mucosal flora in inflammatory bowel disease.

Authors:  Alexander Swidsinski; Axel Ladhoff; Annelie Pernthaler; Sonja Swidsinski; Vera Loening-Baucke; Marianne Ortner; Jutta Weber; Uwe Hoffmann; Stefan Schreiber; Manfred Dietel; Herbert Lochs
Journal:  Gastroenterology       Date:  2002-01       Impact factor: 22.682

4.  Microbiota in pediatric inflammatory bowel disease.

Authors:  Andreas Schwiertz; Manuela Jacobi; Julia-Stefanie Frick; Markus Richter; Kerstin Rusch; Henrik Köhler
Journal:  J Pediatr       Date:  2010-04-18       Impact factor: 4.406

5.  Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial.

Authors:  E Furrie; S Macfarlane; A Kennedy; J H Cummings; S V Walsh; D A O'neil; G T Macfarlane
Journal:  Gut       Date:  2005-02       Impact factor: 23.059

6.  Sulfate-reducing bacteria in human feces and their association with inflammatory bowel diseases.

Authors:  Julien Loubinoux; Jean-Pierre Bronowicki; Ines A C Pereira; Jean-Louis Mougenel; Alain E Faou
Journal:  FEMS Microbiol Ecol       Date:  2002-05-01       Impact factor: 4.194

7.  Identification and quantitation of mucosal and faecal desulfovibrios using real time polymerase chain reaction.

Authors:  A Fite; G T Macfarlane; J H Cummings; M J Hopkins; S C Kong; E Furrie; S Macfarlane
Journal:  Gut       Date:  2004-04       Impact factor: 23.059

8.  Typing of Clostridium perfringens by in vitro amplification of toxin genes.

Authors:  G Daube; B China; P Simon; K Hvala; J Mainil
Journal:  J Appl Bacteriol       Date:  1994-12

9.  The pathogenic role of Bacteroides vulgatus in patients with ulcerative colitis.

Authors:  T Bamba; H Matsuda; M Endo; Y Fujiyama
Journal:  J Gastroenterol       Date:  1995-11       Impact factor: 7.527

10.  The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats.

Authors:  J D Taurog; J A Richardson; J T Croft; W A Simmons; M Zhou; J L Fernández-Sueiro; E Balish; R E Hammer
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

View more
  39 in total

1.  Loss of n-6 fatty acid induced pediatric obesity protects against acute murine colitis.

Authors:  Dorottya Nagy-Szakal; Sabina A V Mir; R Alan Harris; Scot E Dowd; Takeshi Yamada; H Daniel Lacorazza; Nina Tatevian; C Wayne Smith; Edwin F de Zoeten; John Klein; Richard Kellermayer
Journal:  FASEB J       Date:  2015-04-22       Impact factor: 5.191

2.  Reduction of Murine Colon Tumorigenesis Driven by Enterotoxigenic Bacteroides fragilis Using Cefoxitin Treatment.

Authors:  Christina E DeStefano Shields; Sara W Van Meerbeke; Franck Housseau; Hao Wang; David L Huso; Robert A Casero; Heather M O'Hagan; Cynthia L Sears
Journal:  J Infect Dis       Date:  2016-02-21       Impact factor: 5.226

Review 3.  Roles for selenium and selenoprotein P in the development, progression, and prevention of intestinal disease.

Authors:  Sarah P Short; Jennifer M Pilat; Christopher S Williams
Journal:  Free Radic Biol Med       Date:  2018-05-17       Impact factor: 7.376

4.  Virulence factors of Enterococcus strains isolated from patients with inflammatory bowel disease.

Authors:  Edyta Golińska; Anna Tomusiak; Tomasz Gosiewski; Grażyna Więcek; Agnieszka Machul; Diana Mikołajczyk; Małgorzata Bulanda; Piotr B Heczko; Magdalena Strus
Journal:  World J Gastroenterol       Date:  2013-06-21       Impact factor: 5.742

5.  Contrasting Ecological Processes and Functional Compositions Between Intestinal Bacterial Community in Healthy and Diseased Shrimp.

Authors:  Jinyong Zhu; Wenfang Dai; Qiongfen Qiu; Chunming Dong; Jinjie Zhang; Jinbo Xiong
Journal:  Microb Ecol       Date:  2016-08-18       Impact factor: 4.552

Review 6.  Enteric microbiota leads to new therapeutic strategies for ulcerative colitis.

Authors:  Wei-Xu Chen; Li-Hua Ren; Rui-Hua Shi
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

7.  Metabolic alterations to the mucosal microbiota in inflammatory bowel disease.

Authors:  Michael Davenport; Jordan Poles; Jacqueline M Leung; Martin J Wolff; Wasif M Abidi; Thomas Ullman; Lloyd Mayer; Ilseung Cho; P'ng Loke
Journal:  Inflamm Bowel Dis       Date:  2014-04       Impact factor: 5.325

8.  Enterococcus faecalis Gelatinase Mediates Intestinal Permeability via Protease-Activated Receptor 2.

Authors:  Nitsan Maharshak; Eun Young Huh; Chorlada Paiboonrungruang; Michael Shanahan; Lance Thurlow; Jeremy Herzog; Zorka Djukic; Roy Orlando; Rafal Pawlinski; Melissa Ellermann; Luke Borst; Siten Patel; Iris Dotan; Ryan B Sartor; Ian M Carroll
Journal:  Infect Immun       Date:  2015-04-27       Impact factor: 3.441

9.  Dietary α-mangostin, a xanthone from mangosteen fruit, exacerbates experimental colitis and promotes dysbiosis in mice.

Authors:  Fabiola Gutierrez-Orozco; Jennifer M Thomas-Ahner; Lisa D Berman-Booty; Jeffrey D Galley; Chureeporn Chitchumroonchokchai; Thomas Mace; Sunit Suksamrarn; Michael T Bailey; Steven K Clinton; Gregory B Lesinski; Mark L Failla
Journal:  Mol Nutr Food Res       Date:  2014-02-17       Impact factor: 5.914

10.  Composition and function of the pediatric colonic mucosal microbiome in untreated patients with ulcerative colitis.

Authors:  Rajesh Shah; Julia L Cope; Dorottya Nagy-Szakal; Scot Dowd; James Versalovic; Emily B Hollister; Richard Kellermayer
Journal:  Gut Microbes       Date:  2016-05-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.